Tylosine 75 % Kela 750 mg/g Poeder voor gebruik in drinkwater
Tylosine 75 % Kela 750 mg/g Poeder voor gebruik in drinkwater
Authorised
- Tylosin tartrate
Product identification
Medicine name:
Tylosine 75 % Kela 750 mg/g Poeder voor gebruik in drinkwater
Tylosine 75 % Kela 750 mg/g Poudre pour administration dans l’eau de boisson
Tylosine 75 % Kela 750 mg/g Pulver zum Eingeben über das Trinkwasser
Active substance:
- Tylosin tartrate
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Tylosin tartrate825.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Meat and offal1day
-
Eggno withdrawal periodDo not use in animals producing eggs for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Tylosine 75 % Kela 1 Bag with 2000 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 1333 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 1000 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 667 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 500 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 133 g of Powder for use in drinking water
- Tylosine 75 % Kela 1 Bag with 100 g of Powder for use in drinking water
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V216422
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.